BackSolid Biosciences Overview

Solid Biosciences Other Current Liabilities

Track Solid Biosciences's other current liabilities ($22M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$21.99M
↓ 1.15% YoYΔ $-256000.00 vs prior year quarter

Peer average

Loading

Solid Biosciences Other Current Liabilities History

Loading

Solid Biosciences vs. peers: Other Current Liabilities Comparison

Loading

Solid Biosciences Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Solid Biosciences (SLDB) FAQ

As of the most recent data (June 2026), SLDB shows a other current liabilities of $22M. That compares with $22M in the prior-year period — down 1.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLDB's other current liabilities is now $22M (was $22M) — a 1.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Solid Biosciences is outperforming or lagging.

Tracking SLDB's other current liabilities over time shows whether Solid Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $22M That compares with $22M in the prior-year period — down 1.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Solid Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $22M) with ownership activity and broader fundamentals.

Solid Biosciences's other current liabilities is $22M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.